Viewing Study NCT04915404


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-01-01 @ 9:44 PM
Study NCT ID: NCT04915404
Status: TERMINATED
Last Update Posted: 2024-06-06
First Post: 2021-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
Sponsor: WPD Pharmaceuticals Sp. z o.o.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module